Granuflo Questionnaire

GRANUFLO is a product manufactured by Fresenius Medical Care. It is administered during dialysis and is designed to reduce the build-up of acid in the blood which often affects patients with kidney failure. Granuflo contains an ingredient which the body turns into bicarbonate (a buffer in the blood that prevents blood from becoming too acidic); however, Granuflo differs from its competitors in that they use greater concentrations of bicarbonate, which can lead to serious health issues especially if dosage is not properly calculated. Overdoses can cause sudden death and/or heart attacks are the most serious side effects of Granuflo.

If you have suffered a heart attack, stroke, or cardiac arrest following dialysis, or if a loved one has died as a result of taking Granuflo, we can help you.

Fresenius Medical Care published an internal memo on November 4, 2011, regarding risks associated with Granuflo. A reported 941 patients had suffered heart attacks linked to the use of Granuflo, and the memo detailed these “troubling findings”. Medical staff were informed that the problem needed to be “addressed urgently.” However, no contact was made with the Food and Drug Administration about these concerns, and no public warning was issued to patients at risk for Granuflo related side effects. The memo was leaked to the Food and Drug Administration, which prompted a recall of the product.

We believe that Fresenius Medical Care should be held accountable for any harm that they have caused, and that the people who have suffered injuries from taking Granuflo should be treated fairly and compensated for their losses.

We represent all clients suffering from injuries due to being given Granuflo during dialysis on a contingency basis which means that there are never any legal fees unless we win compensation in your case. For a free no-obligation consultation please call our office toll free or fill out our online contact form and we will contact you to answer any of your questions.